Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000919574-18-003940
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-24 17:02:37
Reporting Period:
2018-05-24
Accepted Time:
2018-05-24 17:02:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588972 Recro Pharma Inc. REPH () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1511900 Ltd Fund Master Healthcare Broadfin 20 Genesis Close
Ansbacher House, 2Nd Floor, Po Box 1344
Grand Cayman E9 KY1-1108
No No Yes No
1511901 Broadfin Capital, Llc 300 Park Avenue
25Th Floor
New York NY 10022
No No Yes No
1601692 Kevin Kotler C/o Broadfin Capital, Llc
300 Park Avenue, 25Th Floor
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Per Share Disposition 2018-05-24 29,300 $5.84 2,206,725 No 4 S Direct
Common Stock, $0.01 Par Value Per Share Disposition 2018-05-24 38,000 $5.99 2,168,725 No 4 S Direct
Common Stock, $0.01 Par Value Per Share Disposition 2018-05-24 45,700 $6.00 2,123,025 No 4 S Direct
Common Stock, $0.01 Par Value Per Share Disposition 2018-05-24 50,000 $5.65 2,073,025 No 4 S Direct
Common Stock, $0.01 Par Value Per Share Disposition 2018-05-24 25,000 $5.51 2,048,025 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The Common Stock is held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.